References
Vleeming W, van Amsterdam JGC, Stricker BHCh, et al. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998 Mar; 18(3): 171–88
British National Formulary No. 35. London: The Pharmaceutical Press, 1998 Mar: 140–7
VACSGAA. Low-dose Captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1984; 144: 1947–53
Williams GH. Quality of life and its impact on hypertensive patients. Am J Med 1987; 82: 98–105
Cooper WD, Sheldon D, Brown D, et al. Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice. J R Coll Gen Pract 1987; 37: 346–9
Inman WH, Rawson NS, Wilton LV, et al. Postmarketing surveillance of enalapril. I: results of prescription-event monitoring. BMJ 1988; 297: 826–9
Wood SM, Mann RD, Rawlins MD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. Br Med J Clin Res 1987; 294: 91–2
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234–42
Dyer PD. Late-onset angioedema after interruption of angiotensin converting enzyme inhibitor therapy. J Allergy Clin Immunol 1994 May; 93(5): 947–8
Nielsen EW, Stenberg PA, Einarsen E, et al. Angioedema associated with ACE inhibitors [in Norwegian]. Tidsskr Nor Laegeforen 1994; 114: 804–6
Kostis JB, Shelton B, Gosselin G, et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J 1996 Feb; 131(2): 350–5
Maier C. Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor. Anaesthetist 1995; 44: 875–9
Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260: 967–70
Burkhart GA, Brown NJ, Griffin MR, et al. Angiotensin converting enzyme inhibitor associated angioedema: higher risk in blacks than in whites. Pharmacoepidemiol Drug Saf 1996; 5: 149–54
Brown NJ, Ray WA, Snowden M, et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996 Jul; 60(1): 8–13
Gainer JV, Nadeau JH, Ryder D, et al. Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 1996 Aug; 98(2): 283–7
McElligott S, Perlroth M, Raish L. Angioedema after substituting lisinopril for Captopril [letter]. Ann Intern Med 1992; 116: 426–7
Singer DR, Macgregor GA. Angioneurotic oedema associated with two angiotensin converting inhibitors. BMJ 1986; 293: 1243
Rights and permissions
About this article
Cite this article
ACE inhibitor-induced angioedema: more common than previously thought. Drugs Ther. Perspect 12, 10–12 (1998). https://doi.org/10.2165/00042310-199812100-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199812100-00004